Back

SK pharmteco plans more than $200 million U.S. investment over five years

Verifying
  • SK pharmteco announced a five-year plan to expand U.S. small-molecule and peptide infrastructure.
  • The company will invest more than $200 million and create 100 long-term U.S. jobs.
  • New GMP kilo-scale peptide capacity is scheduled to become operational in late 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.